Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies

Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Objective: The current study aimed to investigate whether cancer antigen 125 (CA-125), tissue polypeptide antigen (TPA) or the combination of both markers are able to act as screening tools for ovarian o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Lars, Domroese, Christian M., Rupp, Alexander B. A., Gihr, Kathrin M. E., Niederau, Christoph, Mallmann, Michael R., Holdenrieder, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669758/
https://www.ncbi.nlm.nih.gov/pubmed/38001961
http://dx.doi.org/10.3390/biomedicines11112960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669758/
https://www.ncbi.nlm.nih.gov/pubmed/38001961
http://dx.doi.org/10.3390/biomedicines11112960

Ejemplares similares